MM+M today announced the 2023 classes of Women of Distinction and Women to Watch.

The Women of Distinction program honors individuals who have held top leadership roles over the course of their careers, while Women to Watch celebrates the leaders of tomorrow. Both programs are in their eighth year.

The 21 Women of Distinction and 18 Women to Watch in this year’s classes hail from a broad range of health-related organizations, including pharma and biotech firms, medical marketing agencies, makers of devices and diagnostics, and the health media.

“The world of medical marketing does not lack for inspiring, accomplished woman leaders,” said MM+M editor-in-chief Larry Dobrow. “For the eighth year in a row, we’re honored to be able to shine a richly deserved spotlight on a group of women who are respected by colleagues and competitors alike. As always, the 2023 classes of Women of Distinction and Women to Watch will represent the best of what this industry has to offer.”

Profiles of the 2023 Women of Distinction and Women to Watch honorees will be published across MM+M’s digital channels in May as well as in the May 2023 print edition of MM+M. Honorees will also be celebrated at an in-person event scheduled for May 15 in New York City. For more information about tickets and sponsorship opportunities, click here.

The 2023 Women of Distinction honorees are:

Heidi Anderson, president and chief growth officer, Nox Health
Sommer Bazuro, chief medical officer, IPG Health
Allison Benson, EVP, client services, life sciences, Merge
Lauren Boyer, CEO, Underscore Marketing
Allison Davis, general manager, Closerlook
Trivia Frazier, president and CEO, Obatala Sciences
Rita Glaze-Rowe, head of market access, Real Chemistry
Margot Grover, EVP, head of strategy, Saatchi & Saatchi Wellness
Beth Jaykus, senior associate director, patient access solutions, Boehringer Ingelheim Pharmaceuticals
Kerri Koppenaal, SVP, director, account services, Boundless Life Sciences Group
Fern Lazar, managing partner, global health practice leader, Finn Partners
Dr. Preeti Parikh, executive medical director, GoodRx; clinical assistant professor of pediatrics, Mount Sinai School Of Medicine        
Susan Perlbachs, chief creative officer, Eversana Intouch
Eleanor Petigrow, global chief growth officer, GCI Group 
Nancy Phelan, SVP, omnichannel activation solutions business, Indegene
Mary Ogle Pietryga, partner, chief commercial officer, director of marketing strategy, Peregrine Market Access
Leslie Pott, VP, communications, North America, Sandoz
Perika Sampson, global head of inclusion and diversity, Gilead Sciences
Donna Wrotny Smith, SVP, executive creative director, Propeller
Kristin Williams, president, Amber Specialty Pharmacy
Pamela Wong, global managing partner, client advice and management, Initiative

The 2023 Women to Watch honorees are:

Nataliya Andreychuk, CEO, Viseven
Alexandra Beneville, VP, life sciences content strategy, Phreesia
Alexis Campione, VP, director, technology, Digitas Health
Carrie Caulkins, VP, U.S. aesthetics marketing, Galderma
Megan Diaz, senior account director, Evoke
Bianca Jay, senior director, marketing, Aurinia Pharmaceuticals
Megan Luther, VP, group account director, Klick Health
Maaza Martin, senior director, marketing, Tarsus Pharmaceuticals
Meghan McNally, VP, integrated marketing, Sharecare
Tami O’Sullivan, consumer and patient strategy, oncology, Merck
Shannon Rittenhouse, senior director, client engagement, Elevate Healthcare
Patty Ryan, GVP, paid social, Publicis Health Media
Christine Schwall-Pecci, VP, medical director, medical strategy and scientific affairs, BGB Group
Michele Sirkin, head of HCP, communications design, Initiative
Lisa Stafford, SVP, learning and performance services, Eversana
Christie Volke, VP, media strategy, AbelsonTaylor
Tiffany Weil, associate director, agency communications, Precisioneffect
Kristin Wong, director, global commercial strategy, customer experience, prostate cancer, Janssen Pharmaceuticals